Search Results - "Satohisa, Seiro"
-
1
ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer
Published in Histochemistry and cell biology (01-08-2020)“…Apoptosis-stimulating p53 protein 2 (ASPP2) is an apoptosis inducer that acts via binding with p53 and epithelial polarity molecule PAR3. Lipolysis-stimulated…”
Get full text
Journal Article -
2
Rap1GAP inhibits tumor progression in endometrial cancer
Published in Biochemical and biophysical research communications (01-04-2017)“…Endometrioid adenocarcinoma (EAC) is a common endometrial cancer with recent dramatic increases in incidence. Previous findings indicate that Rap1GAP acts as a…”
Get full text
Journal Article -
3
Possibility of Targeting Claudin-2 in Therapy for Human Endometrioid Endometrial Carcinoma
Published in Reproductive sciences (Thousand Oaks, Calif.) (01-11-2020)“…Claudin-2 (CLDN-2) is a leaky-type tight junction protein, and its overexpression increases tumorigenesis of some types of cancer cells. In the present study,…”
Get more information
Journal Article -
4
Efficacy of liquid‐based genetic diagnosis of endometrial cancer
Published in Cancer science (01-12-2018)“…Although liquid‐based cytology (LBC) has increased the sensitivity of cytological diagnosis of endometrial cancer (EC) compared with conventional smear…”
Get full text
Journal Article -
5
Localization of Tricellular Tight Junction Molecule LSR at Midbody and Centrosome During Cytokinesis in Human Epithelial Cells
Published in The journal of histochemistry and cytochemistry (01-01-2020)“…Epithelial integrity and barrier function are maintained during cytokinesis in vertebrate epithelial tissues. The changes in localization and the roles of…”
Get full text
Journal Article -
6
Loss of tricellular tight junction protein LSR promotes cell invasion and migration via upregulation of TEAD1/AREG in human endometrial cancer
Published in Scientific reports (10-01-2017)“…Lipolysis-stimulated lipoprotein receptor (LSR) is a unique molecule of tricellular contacts of normal and cancer cells. We investigated how the loss of LSR…”
Get full text
Journal Article -
7
The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells
Published in Oncotarget (10-05-2016)“…Lipolysis-stimulated lipoprotein receptor (LSR) has been identified as a novel molecular constituent of tricellular contacts that have a barrier function for…”
Get full text
Journal Article -
8
The tight-junction protein claudin-6 induces epithelial differentiation from mouse F9 and embryonic stem cells
Published in PloS one (08-10-2013)“…During epithelialization, cell adhesions and polarity must be established to maintain tissue assemblies and separate the biological compartments in the body…”
Get full text
Journal Article -
9
Epithelial barrier dysfunction and cell migration induction via JNK/cofilin/actin by angubindin-1
Published in Tissue barriers (02-01-2020)“…Angulin-1/LSR is a tricellular tight junction molecule, that plays an important role in maintaining the epithelial and endothelial barriers. The actin…”
Get full text
Journal Article -
10
Downregulation of lipolysis-stimulated lipoprotein receptor promotes cell invasion via claudin-1-mediated matrix metalloproteinases in human endometrial cancer
Published in Oncology letters (01-12-2017)“…Lipolysis-stimulated lipoprotein receptor (LSR) is a novel molecule present at tricellular contacts which recruits tricellulin (TRIC), a molecular component of…”
Get full text
Journal Article -
11
ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer
Published in Histochemistry and cell biology (01-08-2020)Get full text
Journal Article -
12
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase-II trial
Published in The journal of obstetrics and gynaecology research (01-10-2015)“…Aim Chemotherapy‐induced nausea and vomiting (CINV) can affect a patient's quality of life, leading to poor compliance with further treatments. Previous…”
Get full text
Journal Article -
13
Possible Involvement of Tight Junctions, Extracellular Matrix and Nuclear Receptors in Epithelial Differentiation
Published in Journal of biomedicine & biotechnology (01-01-2011)“…Tight junctions are intercellular junctions localized at the most apical end of the lateral plasma membrane. They consist of four kinds of transmembrane…”
Get full text
Journal Article -
14
Low-dose SN-38 with paclitaxel induces lethality in human uterine cervical adenocarcinoma cells by increasing caspase activity
Published in Medical molecular morphology (01-03-2014)“…Combination of anticancer drugs may provide a rational molecular basis for novel chemotherapeutic strategies. Paclitaxel and SN-38 (an active metabolite of…”
Get full text
Journal Article -
15
Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium
Published in Cancer letters (28-02-2005)“…In the present study, we analyzed the immunohistochemical findings for the RA receptor (RAR), retinoic X receptor (RXR) and hypermethylation of promoter-region…”
Get full text
Journal Article -
16
Preeclampsia Up-Regulates Angiogenesis-Associated MicroRNA (i.e., miR-17, -20a, and -20b) That Target Ephrin-B2 and EPHB4 in Human Placenta
Published in The journal of clinical endocrinology and metabolism (01-06-2012)“…Context: Placental angiogenesis contributes to the pathogenesis of preeclampsia (PE) that affects 5–8% of all human pregnancies. MicroRNA (miRNA) are a class…”
Get full text
Journal Article -
17
BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer
Published in International journal of oncology (01-07-2016)“…Paclitaxel in combination with carboplatin improves survival among patients with susceptible ovarian cancers, but no strategy has been established against…”
Get full text
Journal Article -
18
ERα increases endometrial cancer cell resistance to cisplatin via upregulation of BAG3
Published in Oncology letters (01-01-2021)“…Endometrial cancer is a leading cause of cancer-associated mortality in women and has a poor prognosis in advanced stages. Our previous study revealed that…”
Get full text
Journal Article -
19
ER[alpha] increases endometrial cancer cell resistance to cisplatin via upregulation of BAG3
Published in Oncology letters (01-12-2020)“…Endometrial cancer is a leading cause of cancer-associated mortality in women and has a poor prognosis in advanced stages. Our previous study revealed that…”
Get full text
Journal Article -
20
BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression
Published in Oncology reports (01-05-2015)“…Approximately 30% of uterine corpus carcinomas are diagnosed at an advanced stage and have a poor prognosis. Our previous study indicated that BCL2-associated…”
Get full text
Journal Article